David Hui1, Renata dos Santos2, Gary B Chisholm3, Eduardo Bruera4. 1. Department of Palliative Care and Rehabilitation Medicine, M. D. Anderson Cancer Center, Houston, Texas, USA. Electronic address: dhui@mdanderson.org. 2. Department of Palliative Care, Barretos Cancer Hospital, Barretos, Brazil. 3. Department of Biostatistics, M. D. Anderson Cancer Center, Houston, Texas, USA; Division of Bioinformatics and Computational Biology, M. D. Anderson Cancer Center, Houston, Texas, USA. 4. Department of Palliative Care and Rehabilitation Medicine, M. D. Anderson Cancer Center, Houston, Texas, USA.
Abstract
CONTEXT: The symptom burden in the last week of life of patients with advanced cancer has not been well characterized. OBJECTIVES: To examine the frequency, intensity, and predictors for symptoms in the last seven days of life among patients who were able to communicate and died in an acute palliative care unit (APCU). METHODS: We systematically documented the Edmonton Symptom Assessment System (ESAS) daily and 15 symptoms twice daily on consecutive advanced cancer patients admitted to APCUs at MD Anderson Cancer Center (U.S.) and Barretos Cancer Hospital (Brazil) from admission to death or discharge in 2010/2011. We examined the frequency and intensity of the symptoms from death backward. RESULTS: A total of 203 of 357 patients died. The proportion of patients able to communicate decreased from 80% to 39% over the last seven days of life. ESAS anorexia (P = 0.001 in longitudinal analyses), drowsiness (P < 0.0001), fatigue (P < 0.0001), poor well-being (P = 0.01), and dyspnea (P < 0.0001) increased in intensity closer to death. In contrast, ESAS depression (P = 0.008) decreased over time. Dysphagia to solids (P = 0.01) and liquids (P = 0.005) as well as urinary incontinence (P = 0.0002) also were present in an increasing proportion of patients in the last few days of life. In multivariate analyses, female sex, non-Hispanic race, and lung cancer were significantly associated with higher ESAS symptom expression (odds ratio > 1). CONCLUSION: Despite intensive management in APCUs, some cancer patients continue to experience high symptom burden as they approached death.
CONTEXT: The symptom burden in the last week of life of patients with advanced cancer has not been well characterized. OBJECTIVES: To examine the frequency, intensity, and predictors for symptoms in the last seven days of life among patients who were able to communicate and died in an acute palliative care unit (APCU). METHODS: We systematically documented the Edmonton Symptom Assessment System (ESAS) daily and 15 symptoms twice daily on consecutive advanced cancerpatients admitted to APCUs at MD Anderson Cancer Center (U.S.) and Barretos Cancer Hospital (Brazil) from admission to death or discharge in 2010/2011. We examined the frequency and intensity of the symptoms from death backward. RESULTS: A total of 203 of 357 patients died. The proportion of patients able to communicate decreased from 80% to 39% over the last seven days of life. ESAS anorexia (P = 0.001 in longitudinal analyses), drowsiness (P < 0.0001), fatigue (P < 0.0001), poor well-being (P = 0.01), and dyspnea (P < 0.0001) increased in intensity closer to death. In contrast, ESAS depression (P = 0.008) decreased over time. Dysphagia to solids (P = 0.01) and liquids (P = 0.005) as well as urinary incontinence (P = 0.0002) also were present in an increasing proportion of patients in the last few days of life. In multivariate analyses, female sex, non-Hispanic race, and lung cancer were significantly associated with higher ESAS symptom expression (odds ratio > 1). CONCLUSION: Despite intensive management in APCUs, some cancerpatients continue to experience high symptom burden as they approached death.
Authors: David Hui; Ahmed Elsayem; Maxine De la Cruz; Ann Berger; Donna S Zhukovsky; Shana Palla; Avery Evans; Nada Fadul; J Lynn Palmer; Eduardo Bruera Journal: JAMA Date: 2010-03-17 Impact factor: 56.272
Authors: Laetitia Veerbeek; Lia van Zuylen; Siebe J Swart; Paul J van der Maas; Agnes van der Heide Journal: Support Care Cancer Date: 2007-03-15 Impact factor: 3.603
Authors: David Hausner; Nanor Kevork; Ashley Pope; Breffni Hannon; John Bryson; Jenny Lau; Gary Rodin; Lisa W Le; Camilla Zimmermann Journal: Support Care Cancer Date: 2018-05-30 Impact factor: 3.603
Authors: Bilal Chughtai; Li Westman; Paul K Maciejewski; Amanda Su; Lindsay Lief; David Berlin; Holly G Prigerson Journal: J Palliat Med Date: 2017-06-30 Impact factor: 2.947
Authors: Sebastiano Mercadante; Federica Aielli; Francesco Masedu; Marco Valenti; Lucilla Verna; Giampiero Porzio Journal: Support Care Cancer Date: 2015-10-16 Impact factor: 3.603
Authors: Omar Shamieh; Odai Khamash; Mustafa Khraisat; Omar Jbouri; Mohammad Awni; Abdulrahman Al-Hawamdeh; Ghadeer Arja; Sawsan Ajarmeh; Dalia Al-Rimawi; David Hui Journal: Support Care Cancer Date: 2016-09-07 Impact factor: 3.603
Authors: Miguel Angel Benítez-Rosario; Inmaculada Rosa-González; Enrique González-Dávila; Emilio Sanz Journal: Support Care Cancer Date: 2018-06-18 Impact factor: 3.603
Authors: David Hui; Kelly Kilgore; Susan Frisbee-Hume; Minjeong Park; Anne Tsao; Marvin Delgado Guay; Charles Lu; William William; Katherine Pisters; George Eapen; Frank Fossella; Sapna Amin; Eduardo Bruera Journal: J Pain Symptom Manage Date: 2016-06-18 Impact factor: 3.612